Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Baylor College of Medicine
- Duke University
- Fred Hutchinson Cancer Center
- Stanford University
- University of Gdansk
- University of Washington
- Yale University
- CNRS
- Massachusetts Institute of Technology
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Florida
- University of Kentucky
- University of Minnesota
- Aarhus University
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Human Technopole
- Indiana University
- Institut Pasteur
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Institute of Macromolecular Chemistry CAS
- Lunds universitet
- Luxembourg Institute of Health
- MAYNOOTH UNIVERSITY
- Massachusetts Institute of Technology (MIT)
- Maynooth University
- Michigan State University
- Nencki Institute of Experimental Biology
- Pennsylvania State University
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- Rutgers University
- SUNY University at Buffalo
- St Jude Children's Research Hospital
- The Wistar Institute
- Umeå University
- University Hospital Magdeburg
- University of California San Diego - Ganesan Lab
- University of California, Los Angeles
- University of Colorado
- University of Kansas Medical Center
- University of Louisville
- University of Maryland, Baltimore
- University of Miami
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- Utrecht University
- Washington University in St. Louis
- 37 more »
- « less
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 28 days ago
, Polymers, Chemo- and immunotherapy, RNA Vaccines, Computational Chemistry, PK/PD, Translational Research Special Physical/Mental Requirements Special Instructions This is an NIH/NCI sponsored postdoctoral
-
inflammatory bowel diseases, optimization of checkpoint cancer immunotherapy, complications of liver disease, autism, C. difficile infections, and others. This provides a unique model for real-world drug
-
Summary: NIH-funded postdoctoral positions in cancer immunotherapy are immediately available in the laboratory of Dr. Richard Tobin, in the Department of Surgery at University of Colorado School of Medicine
-
clinical research initiatives within the Sylvester Myeloma Institute focused on identifying biomarkers of response and resistance to BCMA-targeted immunotherapies in patients with relapsed/refractory
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
develop novel cancer immunotherapy targeting newly discovered immune regulators. These positions are supported for first-year postdoctoral scholars who are committed to building an independent research
-
rigorously investigate systemic immunity, the tumor microenvironment (TME), and the mechanistic drivers of resistance to radiation and immunotherapy utilizing advanced pre-clinical models of head/neck and
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on use of cancer specific T cells